IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Docket No.: 32328/55344P
`(PATENT)
`
`In re Provisional Application of:
`Igor Ivanovich Rybkin
`
`Application No.: 63/355,695
`
`Confirmation No.: 1076
`
`Filed: June 27, 2022
`
`Art Unit: Not Yet Assigned
`
`For: METHODS FOR TREATING CANCER
`
`Examiner: Not Yet Assigned
`
`REQUEST FOR CORRECTED FILING RECEIPT
`
`Office of Initial Patent Examination's Filing Receipt Corrections
`Commissioner for Patents
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`Dear Sir:
`
`Applicant hereby requests that a corrected Filing Receipt be issued in the above-
`
`identified patent application. The official updated Filing Receipt received by Applicant, a
`
`copy of whichis attached hereto, has been marked-up to include the inventor. Please add
`
`the following inventor to the Inventor (s) section:
`
`-- Igor Ivanovich Rybkin, Thousand Oaks, CA;--
`
`Applicant additionally requests that all pertinent U.S. Patent and Trademark Office
`
`recordsrelating to the subject application be changedto reflect this correction.
`
`Dated: December 20, 2022
`
`Respectfully submitted,
`
`
`Electronic signature:/Jeanne M. Brashear/56,301
`Jeanne M. Brashear
`Registration No.: 56,301
`MARSHALL, GERSTEIN & BORUN LLP
`233 S. WackerDrive
`6300 Willis Tower
`Chicago, Illinois 60606-6357
`(312) 474-6300
`Agent for Applicant
`
`

`

`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`Q. Box 1450
`Alexandria, Virginia 22313-1450
`www.uspto.gov
`
`APPLICATION
`NUMBER
`
`FILINGor
`371(c) DATE
`
`GRP ART
`UNIT
`
`
`
`
`
`FIL
`
`63/355,695
`
`06/27/2022
`
`FEE REC'D
`
`300
`
`ATTY.DOCKET.NO
`
`32328/55344P
`
`ITOT CLAIMSJIND CLAIMS
`
`109438
`Marshall, Gerstein & B
`
`233South Wacker Dive
`
`LLP (A
`
`6300 Willis Tower
`Chicago, IL 60606-6357
`
`CONFIRMATIONNO. 1076
`FILING RECEIPT
`
`NEAMLALQ
`
`Date Mailed: 07/13/2022
`
`It will not be examined for patentability and will
`Receipt is acknowledged of this provisional patent application.
`become abandonednotlater than twelve monthsafter its filing date. Any correspondence concerning the application
`mustinclude the following identification information: the U.S. APPLICATION NUMBER, FILING DATE, NAME OF
`FIRST INVENTOR, and TITLE OF INVENTION. Fees transmitted by check or draft are subject to collection.
`
`Pleaseverify the accuracy of the data presented on this receipt.If an error is noted on this Filing Receipt, please
`submit a written request for a corrected Filing Receipt identifying the requested changes, preferably by including a
`properly marked-up ADS showing the changeswith strike-through for deletions and underlining for additions. If you
`received a "Notice to File Missing Parts" or other Notice requiring a responsefor this application, please submit any
`requestfor correction to this Filing Receipt with your reply to the Notice. When the USPTOprocessesthe reply to
`the Notice, the USPTO will generate another Filing Receipt incorporating the requested corrections provided that
`the requestis grantable.
`
`Inventor(s)
`
`Applicant(s)
`
`Nene
`
`
`Igor Ivanovich Rybkin, Thousand Oaks, CA;
`
`AMGEN INC., Thousand Oaks, CA;
`
`Powerof Attorney:
`Shelley Danek--57712
`
`Permission to Access Application via Priority Document Exchange: Yes
`
`Permission to Access Search Results: Yes
`
`Applicant may provide or rescind an authorization for access using Form PTO/SB/39 or Form PTO/SB/69 as
`appropriate.
`
`If Required, Foreign Filing License Granted: 07/12/2022
`
`The country code and number of your priority application, to be usedfor filing abroad under the Paris Convention,
`is US 63/355,695
`
`Projected Publication Date: None, application is not eligible for pre-grant publication
`
`Non-Publication Request: No
`
`Early Publication Request: No
`
`page 1 of 3
`
`

`

`Title
`
`METHODS FOR TREATING CANCER
`
`Statement under 37 CFR 1.55 or 1.78 for AIA (First Inventorto File) Transition Applications: No
`
`PROTECTING YOUR INVENTION OUTSIDE THE UNITED STATES
`
`Since the rights granted by a U.S. patent extend only throughout the territory of the United States and have no
`effect in a foreign country, an inventor who wishes patent protection in another country must apply for a patent
`in a specific country or in regional patent offices. Applicants may wish to consider the filing of an international
`application under the Patent Cooperation Treaty (PCT). An international (PCT) application generally has the same
`effect as a regular national patent application in each PCT-member country. The PCT process simplifies thefiling
`of patent applications on the same invention in member countries, but does not result in a grant of "an international
`patent" and doesnot eliminate the need of applicantsto file additional documents and fees in countries where patent
`protection is desired.
`
`Almost every country has its own patent law, and a person desiring a patent in a particular country must make an
`application for patent in that country in accordancewithits particular laws. Since the laws of many countries differ
`in various respects from the patent law of the United States, applicants are advised to seek guidance from specific
`foreign countries to ensure that patent rights are not lost prematurely.
`
`Applicants also are advisedthatin the case of inventions madein the United States, the Director of the USPTO must
`issue a license before applicants can apply for a patent in a foreign country. Thefiling of a U.S. patent application
`serves as a request for a foreign filing license. The application'sfiling receipt contains further information and
`guidance asto the status of applicant's license for foreign filing.
`
`Applicants may wish to consult the USPTO booklet, "General Information Concerning Patents” (specifically, the
`section entitled "Treaties and Foreign Patents") for more information on timeframes and deadlinesfor filing foreign
`patent applications. The guide is available either by contacting the USPTO Contact Center at 800-786-9199, or it
`can be viewed on the USPTO website at http:/(www.uspto.gov/web/offices/pac/doc/general/index.html.
`
`For information on preventing theft of your intellectual property (patents, trademarks and copyrights), you may wish
`to consult the U.S. Government website, http://www.stopfakes.gov. Part of a Department of Commerceinitiative,
`this website includes self-help "toolkits" giving innovators guidance on how to protectintellectual property in specific
`countries such as China, Korea and Mexico. For questions regarding patent enforcement issues, applicants may
`call the U.S. Governmenthotline at 1-866-999-HALT (1-866-999-4258).
`
`LICENSE FOR FOREIGN FILING UNDER
`
`Title 35, United States Code, Section 184
`
`Title 37, Code of Federal Regulations, 5.11 & 5.15
`
`GRANTED
`
`if the phrase "IF REQUIRED, FOREIGN FILING
`The applicant has been granted a license under 35 U.S.C. 184,
`LICENSE GRANTED"followed by a date appears on this form. Such licenses are issuedin all applications where
`the conditions for issuance of a license have been met, regardless of whether or not a license may be required as
`set forth in 37 CFR 5.15. The scope andlimitations of this license are set forth in 37 CFR 5.15(a) unless an earlier
`
`page 2 of 3
`
`

`

`license has been issued under 37 CFR 5.15(b). The license is subject to revocation upon written notification. The
`date indicatedis the effective date of the license, unless an earlier license of similar scope has been granted under
`37 CFR 5.13 or 5.14.
`
`This licenseis to be retained by the licensee and maybe usedat any time onor after the effective date thereof unless
`it is revoked. This license is automatically transferred to any related applications(s) filed under 37 CFR 1.53(d). This
`license is not retroactive.
`
`The grantof a license does notin any way lessen the responsibility of a licensee for the security of the subject matter
`as imposed by any Governmentcontract or the provisions of existing laws relating to espionage and the national
`security or the export of technical data. Licensees should apprise themselves of current regulations especially with
`respect to certain countries, of other agencies, particularly the Office of Defense Trade Controls, Department of
`State (with respect to Arms, Munitions and Implements of War (22 CFR 121-128)); the Bureau of Industry and
`Security, Department of Commerce (15 CFR parts 730-774); the Office of Foreign AssetsControl, Department of
`Treasury (31 CFR Parts 500+) and the Department of Energy.
`
`NOT GRANTED
`
`No license under 35 U.S.C. 184 has been granted atthis time, if the phrase "IF REQUIRED, FOREIGN FILING
`LICENSE GRANTED" DOES NOTappear on this form. Applicant maystill petition for a license under 37 CFR 5.12,
`if a license is desired before the expiration of 6 monthsfrom thefiling date of the application. If 6 months has lapsed
`from thefiling date of this application and the licensee has not received any indication of a secrecy order under 35
`U.S.C. 181, the licensee may foreign file the application pursuant to 37 CFR 5.15(b).
`
`
`SelectUSA
`
`The United States represents the largest, most dynamic marketplacein the world and is an unparalleled location for
`business investment, innovation, and commercialization of new technologies. The U.S. offers tremendous resources
`and advantages for those who invest and manufacture goods here. Through SelectUSA, our nation works to
`promote andfacilitate business investment. SelectUSA provides information assistance to the international investor
`community; serves as an ombudsmanfor existing and potential investors; advocates on behalf of U.S. cities, states,
`and regions competing for global investment; and counsels U.S. economic developmentorganizations on investment
`attraction best practices. To learn more about why the United States is the best country in the world to develop
`technology, manufacture products, deliver services, and grow your business, visit http:/Awww.SelectUSA.govor call
`+1-202-482-6800.
`
`page 3 of 3
`
`